ESR1 and bladder transitional cell carcinoma: Biologically active estrogens, which can bind the ERs, could ameliorate bladder urothelial carcinoma progression, and this is considered at least one of the reasons why SERMs could suppress the proliferation and invasion of urinary bladder urothelial carcinoma via ER-dependent induction [19, 20, 30–32].